Compounds > n-n-dimethyl-n-(18f)fluoromethyl-2-hydroxyethylammonium

n-n-dimethyl-n-(18f)fluoromethyl-2-hydroxyethylammonium and Breast-Neoplasms

n-n-dimethyl-n-(18f)fluoromethyl-2-hydroxyethylammonium has been researched along with Breast-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for n-n-dimethyl-n-(18f)fluoromethyl-2-hydroxyethylammonium and Breast-Neoplasms

Article	Year
18F-Choline PET/CT in Leptomeningeal Breast Cancer Metastases. Clinical nuclear medicine, 2019, Volume: 44, Issue:2 We describe a case of 47-year-old woman affected by human epidermal growth factor receptor-2-positive breast cancer with a diffuse leptomeningeal carcinomatosis. An intense uptake of F-choline was reported at fused PET/MRI images in the brain, compatible with a diffuse leptomeningeal disease. This case highlights that F-choline PET would be used for the identification of leptomeningeal involvement in patients affected by breast cancer, as a support of MRI images. Topics: Breast Neoplasms; Choline; Female; Humans; Meningeal Carcinomatosis; Middle Aged; Positron Emission Tomography Computed Tomography	2019

Article

Year

18F-Choline PET/CT in Leptomeningeal Breast Cancer Metastases.

Clinical nuclear medicine, 2019, Volume: 44, Issue:2

We describe a case of 47-year-old woman affected by human epidermal growth factor receptor-2-positive breast cancer with a diffuse leptomeningeal carcinomatosis. An intense uptake of F-choline was reported at fused PET/MRI images in the brain, compatible with a diffuse leptomeningeal disease. This case highlights that F-choline PET would be used for the identification of leptomeningeal involvement in patients affected by breast cancer, as a support of MRI images.

Topics: Breast Neoplasms; Choline; Female; Humans; Meningeal Carcinomatosis; Middle Aged; Positron Emission Tomography Computed Tomography

2019